Increase in adoption of lightweight and high-performance materials in various end-use industries is also boosting demand for polycaprolactone.Wilmington, Delaware, United States, Nov. 16, 2023 (GLOBE NEWSWIRE) Transparency Market Research Inc. - The global polycaprolactone market stood at US$ 500 million in 2023 and is projected to reach US$ 1.1 billion in 2031. The global polycaprolactone market is anticipated to expand at a CAGR of 9.5% between 2023 and 2031. Polycaprolactone (PCL) is a par
/PRNewswire/ DURECT Corporation (Nasdaq: DRRX), a late-stage biopharmaceutical company pioneering the development of epigenetic therapies to transform the.
Health care stocks were mixed late Wednesday afternoon, with the NYSE Health Care Index little changed and the Health Care Select Sector SPDR Fund down 0.1%.
The iShares Biotechnology ETF fell.
Let’s talk about penny stocks. These are equities that trade for less than $5 per share, at the very bottom of the price range. While they are priced that low for a reason – and the reasons may vary – a low price in itself doesn’t mean that the stock’s fundamentals are sour. Smart investors can find some true bargains among penny stocks and set themselves up for outsized gains. The opportunity is linked to a simple question: Why is the company’s stock priced so low? If the answer is mainly benig